This company seems to have been delisted
Reason: Acquired by EQT-led Consortium
Last recorded trade on: March 19, 2024
Source: https://www.loyensloeff.com/insights/news--events/news/eqt-led-consortium-acquires-dechra-pharmaceuticals-plc/
Reason: Acquired by EQT-led Consortium
Last recorded trade on: March 19, 2024
Source: https://www.loyensloeff.com/insights/news--events/news/eqt-led-consortium-acquires-dechra-pharmaceuticals-plc/
Dechra Pharmaceuticals
DPH.L
$85.48
Share price
0.05%
Change (1 day)
65.25%
Change (1 year)
Categories
Revenue for Dechra Pharmaceuticals (DPH.L)
Revenue in 2023: NZ$1.67 Billion
According to Dechra Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is NZ$1.67 Billion. In 2023 the company made a revenue of NZ$1.67 Billion an increase over the revenue in the year 2022 that were of NZ$1.43 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Dechra Pharmaceuticals from 1998 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | NZ$1.67 B | 16.13% |
| 2022 | NZ$1.43 B | -1.72% |
| 2021 | NZ$1.46 B | 32.73% |
| 2020 | NZ$1.10 B | 3.68% |
| 2019 | NZ$1.06 B | 13.75% |
| 2018 | NZ$0.93 B | 15.02% |
| 2017 | NZ$0.81 B | 40.23% |
| 2016 | NZ$0.57 B | 4.14% |
| 2015 | NZ$0.55 B | -2.92% |
| 2014 | NZ$0.57 B | 14.63% |
| 2013 | NZ$0.50 B | -56.95% |
| 2012 | NZ$1.16 B | 6.77% |
| 2011 | NZ$1.08 B | 13.36% |
| 2010 | NZ$0.96 B | -4.21% |
| 2009 | NZ$1.00 B | -5% |
| 2008 | NZ$1.05 B | 18.45% |
| 2007 | NZ$0.89 B | 19.14% |
| 2006 | NZ$0.74 B | 14.19% |
| 2005 | NZ$0.65 B | 10.69% |
| 2004 | NZ$0.59 B | 10.36% |
| 2003 | NZ$0.53 B | 43.26% |
| 2002 | NZ$0.37 B | 8.82% |
| 2001 | NZ$0.34 B | 7.5% |
| 2000 | NZ$0.31 B | 11.26% |
| 1999 | NZ$0.28 B | 6.42% |
| 1998 | NZ$0.27 B |